Cerecor Inc. Purchase Agreements
14 Contracts & Agreements
- Asset Purchase Agreement, dated December 6, 2023, by and among AlmataBio, Inc., Leap Therapeutics, Inc., and Flame Biosciences LLC (Filed With SEC on May 13, 2024)
- Securities Purchase Agreement, dated March (Filed With SEC on March 28, 2024)
- Purchase Agreement, dated September 11, 2023, by and between AUG Therapeutics, LLC and Avalo Therapeutics, Inc (Filed With SEC on September 12, 2023)
- Purchase Agreement, dated November 4, 2022, by and between ES Therapeutics, LLC and Avalo Therapeutics, Inc (Filed With SEC on November 7, 2022)
- Securities Purchase Agreement, dated March 17, 2020, between Cerecor Inc. and the investor(s) named therein (Filed With SEC on March 18, 2020)
- Form of Securities Purchase Agreement, dated February 3, 2020 (Filed With SEC on February 4, 2020)
- First Amendment to the Asset Purchase Agreement, dated November 1, 2019, by and between Cerecor Inc. and Aytu Bioscience, Inc (Filed With SEC on November 4, 2019)
- Securities Purchase Agreement, dated September 4, 2019, between Cerecor Inc. and the investor(s) named therein (Filed With SEC on September 9, 2019)
- Securities Purchase Agreement, dated December 27, 2018, between Cerecor Inc. and Armistice Capital Master Fund Ltd (Filed With SEC on December 27, 2018)
- Securities Purchase Agreement, dated August 17, 2018, between Cerecor Inc. and the investor(s) named therein (Filed With SEC on August 20, 2018)
- Asset Purchase Agreement, dated February 12, 2018, by and between Cerecor Inc., Avadel US Holdings, Inc., Avadel Pharmaceuticals (USA), Inc., Avadel Pediatrics, Inc., Avadel... (Filed With SEC on May 11, 2018)
- Equity Interest Purchase Agreement, dated November 17, 2017, by and among Cerecor Inc., TRx Pharmaceuticals, LLC, Fremantle Corporation and LRS International LLC, the selling... (Filed With SEC on November 17, 2017)
- ASSET PURCHASE AGREEMENT Dated as of August 14, 2017 between JANSSEN PHARMACEUTICALS, INC. and CERECOR INC. (Filed With SEC on August 14, 2017)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on April 28, 2017)
